SENSEX
NIFTY
GOLD
USD/INR

Weather

image 35    C

Economy News

The Economic Times

Economy / The Economic Times

details

Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration deal

Sun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. Significant progress is being made on the acquisition of Organon, with completion targeted for the last quarter of FY2027. This strategic move is set to enhance Sun Pharma's global presence and product portfolio across key therapeutic areas.

23 May 2026 12:59 am